LYFT Inc vs McKesson Corporation — how do they compare? LYFT Inc trades at $17.5 (market cap $6.64B), while McKesson Corporation trades at $895 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 15.8× LYFT Inc's market cap, and McKesson Corporation pays a 0.42% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.
| LYFT | MCK | |
|---|---|---|
Market Cap | $6.64B | $105.14B |
Sector | Industrials | Health |
52-Week High | $24.57 | $995.69 |
52-Week Low | $12.65 | $659.01 |
Enterprise Value | $6.11B | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
Latest headlines on both assets
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →